Tejas Patil

Non–Small Cell Lung Cancer, Version 4.2024

Gregory J. Riely, Douglas E. Wood, David S. Ettinger et al. · Journal of the National Comprehensive Cancer Network · 2024 · 614 citations

Tumor Biology, Actionable Molecular Biomarkers, Advanced Lung Disease +14

NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. · Journal of the National Comprehensive Cancer Network · 2023 · 449 citations · Full text

Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

William J. Magnuson, N.H. Lester-Coll, Abraham J. Wu et al. · Journal of Clinical Oncology · 2017 · 448 citations

Neuro-oncology, Brain Metastases, Radiation Therapy +15

The Incidence of Brain Metastases in Stage IV ROS1-Rearranged Non–Small Cell Lung Cancer and Rate of Central Nervous System Progression on Crizotinib

Tejas Patil, Derek Smith, Paul A. Bunn et al. · Journal of Thoracic Oncology · 2018 · 193 citations · Full text

Neuro-oncology, Tumor Innervation, Brain Metastases +8

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC

Alexander Drilon, Chao‐Hua Chiu, Yun Fan et al. · JTO Clinical and Research Reports · 2022 · 111 citations · Full text